| Product Information |
DR-XY39925_PI_01.pdf
|
| Registration Number |
DR-XY39925
|
| Generic Name |
Pazopanib (as Hydrochloride)
|
| Brand Name |
Votrient
|
| Dosage Strength |
400 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
Antineoplastic (Tyrosine kinase inhibitor)
|
| Packaging |
White HDPE Bottle with polypropylene child-resistant closure and sealed with a poly(ethylene-vinyl acetate) x
and s 30's (Box of 30's)
|
| Manufacturer |
Lek Pharmaceuticals d.d.
|
| Country of Origin |
Slovenia
|
| Trader |
|
| Importer |
Novartis Healthcare Philippines, Inc.
|
| Distributor |
Novartis Healthcare Philippines, Inc.
|
| Application Type |
Initial (Variation)
|
| Issuance Date |
18 April 2024
|
| Expiry Date |
18 April 2029
|